Sibboran - Landiolol Hydrochloloride
Trimedic Therapeutics has introduced Sibboran, an ultra-short acting beta-blocker.
Indication
The short-term reduction of ventricular rate in patients with supraventricular tachycardia including atrial fibrillation and atrial flutter in perioperative, postoperative, or other acute circumstances where short-term control of the ventricular rate with a short acting agent is desirable.
